University Multiprophy Hospital For Active Treatment - Plovdiv AD
- Address
- lock Available on a paid plan
Respiratory and Cardiovascular Research
At University Multiprophy Hospital For Active Treatment - Plovdiv AD, clinical research in Respiratory Tract Diseases and Cardiovascular Diseases focuses on conditions such as Chronic Obstructive Pulmonary Disease and Atrial Fibrillation. These studies are designed to assess how well new treatments can reduce symptoms and serious health events, while also supporting better disease control for patients with complex long-term needs.
- COPD studies evaluating new approaches to lower exacerbations and improve breathing-related outcomes
- Atrial Fibrillation research examining whether novel therapies can reduce stroke risk in patients who cannot use standard anticoagulation
This area reflects a strong interest in testing therapies that may improve safety and effectiveness in common but serious chronic diseases.
Immune-Mediated and Rheumatologic Disease Studies
The Rheumatology Department is actively involved in trials for Immune System Diseases and Musculoskeletal Diseases, including Rheumatoid Arthritis, Psoriatic Arthritis, Axial Spondyloarthritis, and Sjögren’s syndrome. Research here aims to improve symptom control, reduce inflammation, and evaluate the long-term safety of newer treatment options for people living with chronic autoimmune conditions.
- Rheumatoid Arthritis studies comparing advanced therapies to improve disease control after prior treatment failure
- Psoriatic Arthritis and Axial Spondyloarthritis trials assessing whether emerging medicines can ease joint and spine-related symptoms
- Sjögren’s syndrome research focused on long-term safety and tolerability of treatment
These trials highlight a broad effort to refine care for inflammatory and autoimmune diseases that can affect both quality of life and daily function.
Bone Health and Osteoporosis Research
Clinical trials at this site also cover Musculoskeletal Diseases through studies in Post-Menopausal Osteoporosis. The main purpose is to compare treatment effects on bone strength and biological markers, helping determine whether new options can support bone preservation and reduce the risk of fractures in post-menopausal women.
- Post-Menopausal Osteoporosis research evaluating whether a newer bone-protective therapy performs similarly to an established treatment
This research area is important for improving long-term bone health and supporting more effective osteoporosis management.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 4 of 8 therapeutic areas and 15 of 43 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Top 40 of 43 compounds, ranked by number of trials.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 18 by active trials.
- 1AstraZeneca AB3active
lock +17 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1AstraZeneca AB4trials
lock +5 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 476 other sites in Bulgaria
Therapeutic Area Benchmark — Bulgaria
Select a therapeutic area to compare against other sites in Bulgaria.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Bulgaria
Market Share
Country: Bulgaria
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in University Multiprophy Hospital For Active Treatment - Plovdiv AD
lock Showing 1 of 35 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| 22104: A Randomized, Double-blind, Placebo-controlled, Multicenter Phase 2b/3 Study to Evaluate the Efficacy and Safety of Izokibep in Subjects with Active Psoriatic Arthritis | Acelyrin Inc. | Phase IV | Not Recruiting | Apr 2023 | Oct 2024 |
IMP list
lock Showing 1 of 43 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Dapagliflozin | 2 | Unknown | 2024-07-12 | 2025-05-06 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.